Krka is a nice defensive business. So far it seems they managed Russia well, get most money out, at close to official exchange rates (ie Bloomberg). RUB Hedging not possible anymore, though.
Thank you for the insightful comment! I totally agree about the defensive nature of the business, I like that! Pharmaceutical products are likely the last to be sanctioned, but I have the concern, that maybe Russia has an interest to replace imports from EU-Countries with imports from India, China or other more russian-friendly countries. But I have no strong opinion or insight here, it's just worrying to see that so much of their business is done in Russia.
There is a lot to like about Doc Martens, but as you say the sales forecasts for them are not ideal
I wonder if they will double down on the direct to consumer strategy or go back to relying on retail partners
Krka is a nice defensive business. So far it seems they managed Russia well, get most money out, at close to official exchange rates (ie Bloomberg). RUB Hedging not possible anymore, though.
Thank you for the insightful comment! I totally agree about the defensive nature of the business, I like that! Pharmaceutical products are likely the last to be sanctioned, but I have the concern, that maybe Russia has an interest to replace imports from EU-Countries with imports from India, China or other more russian-friendly countries. But I have no strong opinion or insight here, it's just worrying to see that so much of their business is done in Russia.